Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney Disease
Noninvasive Detection of Diabetic Kidney Disease Based on Automatic Segmentation Ultrasound-based Radiomics Technology
1 other identifier
observational
499
1 country
3
Brief Summary
Diabetic kidney disease is a common complication of diabetes and the main cause of end-stage renal disease. In this study, the investigator plan to enroll nearly 500 participant with/without DKD and to develop an automatic segmentation ultrasound based radiomics technology to differentiating participant with a non-invasive and an available way.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 24, 2021
CompletedFirst Posted
Study publicly available on registry
August 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedFebruary 16, 2022
August 1, 2021
6 months
August 24, 2021
February 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AUC
The area under curve (AUC) of radiomics model for differentiating DKD and T2DM or high level and low level DKD patients
6 months
Secondary Outcomes (2)
Miou
6 months
mPA
6 months
Study Arms (2)
Experimental group
Experimental group1:DKD patients with Type 2 diabetes patients with DKD Experimental group2:High level DKD patients with diabetic kidney disease Stage III and IV.
Control group
Control1:T2DM patients with Type 2 diabetes Control2:Low level DKD patients with diabetic kidney disease Stage I and II.
Interventions
Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.
Eligibility Criteria
1. patients with diabetes 2. patients with or without DKD
You may qualify if:
- patients with clinical diagnosis of T2DM and DKD were enrolled.
- patients with clear B mode ultrasound imaging in both side of kidney (left and right).
- No missing value in the vital clinical data such as eGFR and UACR.
You may not qualify if:
- Patients with large kidney space occupying disease such as kidney renal cyst and tumor were excluded.
- Ultrasound images with severe shadow or incomplete kidney border were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
The People's Hospital of Yingshang
Fuyang, Anhui, 236200, China
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality, 300000, China
Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pintong Huang
Department of Ultrasound, The Second Affiliated Hospital of Zhejiang University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2021
First Posted
August 27, 2021
Study Start
June 1, 2021
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
February 16, 2022
Record last verified: 2021-08